Research Article
Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study
Table 1
Pathological characteristics of breast cancer patients.
| Tumor characteristics | Patient number | % |
| All patients | 52 | 100 | Tumor size () | | | cm | 38 | 73 | cm | 14 | 27 | Lymph node () | | | | 39 | 75 | | 13 | 25 | Estrogen receptor | | | (−) | 10 | 19 | (+) | 42 | 81 | Progesterone receptor | | | (−) | 13 | 25 | (+) | 39 | 75 | Her2-neu | | | (−) | 41 | 79 | (+) | 8 | 15 | Missing | 3 | 6 | Triple negative | | | Absent | 43 | 83 | Present | 6 | 11 | Missing | 3 | 6 | Tumor grade | | | Grade 1 | 10 | 19 | Grade 2 | 27 | 52 | Grade 3 | 15 | 29 | LVI | | | Absent | 42 | 81 | Present | 7 | 13 | Missing | 3 | 6 | ECE | | | Absent | 48 | 92 | Present | 4 | 8 | Ki-67 receptor | | | <15 | 10 | 19 | ≥15 | 13 | 25 | Missing | 29 | 56 |
|
|
LVI: lymphovascular invasion and ECE: extracapsular extension.
|